Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 108.33% vs -23.40% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 52.82% vs 30.09% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -0.85% vs 29.34% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 20.00% vs -9.09% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Editas Medicine, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 108.33% vs -23.40% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 7,400.00% vs -98.11% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 52.82% vs 30.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 59.58% vs -38.00% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -0.85% vs 29.34% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 62.87% vs -31.89% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 20.00% vs -9.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






